Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Allocation / Balanced · Venerable Variable Insurance

Venerable Moderate Allocation Fund (VMAVX)

Ticker VMAVX · Since 2024-09-04 · · Holdings as of Jun 30, 2026

Expense ratio
0.5%$50/yr per $10k
1-yr return
+12.6%as of Dec 2025
Net assets
$2.1Ball share classes
Holdings
4

Bottom line

Is VMAVX a good fund? The bottom line

VMAVX is a managed allocation / balanced mutual fund from Venerable Variable Insurance.

Its expense ratio is 0.5% — about $50 a year on every $10,000 invested, cheaper than 87% of allocation / balanced funds we track.

It returned +12.6% over one year (as of Dec 31, 2025, per its prospectus).

With $2.1 billion in net assets and 4 holdings, its largest position is Venerable US Large Cap Core Equity Fund (30.1%) and the top 10 make up 100% of the portfolio.

What stands out

  • Low cost: cheaper than 87% of allocation / balanced peers

What to watch

  • Concentrated: top 10 holdings are 100% of assets
  • 12b-1 marketing fee of 0.3% a year

Updated Nov 19, 2026

What VMAVX invests in

"The Venerable Moderate Allocation Fund (the ""Fund"") seeks, over the long-term, total investment return consistent with the preservation of capital."

"The Fund is a ""fund of funds"" that seeks to achieve its objective by investing in the other series of Venerable Variable Insurance Trust (the ""Underlying Funds"") including, but not limited to, the following equity funds Venerable US Large Cap Core Equity Fund and Venerable US Large Cap Strategic Equity Fund and the following fixed income funds Venerable Strategic Bond Fund and Venerable High Yield Fund. The Fund's strategy of investing in a combination of Underlying Funds is intended to result in investment diversification that an investor could otherwise achieve only by holding numerous individual investments. The Adviser has engaged Russell Investment Management, LLC (""RIM"") to provide the day-to-day management of the Fund's portfolio pursuant to investment guidelines provided by the Adviser. The Fund's approximate target strategic asset allocation among the Underlying Funds…

From the fund's prospectus (filed Apr 29, 2026).

VMAVX performance

Fund calendar-year total returns, 2025–2025 2025: +12.6% +12.6% 2025
Fund gain (+)
Average annual total returns
1 yr5 yr10 yr
VMAVX+12.6%——
Allocation / Balanced median+11.0%+5.7%+6.7%

Source: Fund prospectus, as of Dec 31, 2025

Full VMAVX performance history →

What VMAVX costs

On a $10,000 investment, VMAVX's 0.5% expense ratio costs about $50 a year. The prospectus estimates $1,466 in total costs over 10 years (assuming 5% annual returns). The median allocation / balanced fund charges 0.91%.

See the full VMAVX fee table →

VMAVX top 10 holdings

#Holding% of fund
1Venerable US Large Cap Core Equity Fund30.14%
2Venerable US Large Cap Strategic Equity Fund30.12%
3Venerable High Yield Fund19.91%
4Venerable Strategic Bond Fund19.85%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 100% of the fund. See all top 25 holdings and asset mix →

Alternatives to VMAVX

More funds like VMAVX →

VMAVX FAQ

What is the expense ratio of VMAVX?
VMAVX's expense ratio is 0.5%, which works out to about $50 a year for every $10,000 invested. The prospectus estimates total costs of $1,466 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is VMAVX a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 87% of allocation / balanced peers; concentrated: top 10 holdings are 100% of assets; 12b-1 marketing fee of 0.3% a year. This is general information, not personalized advice.
What does VMAVX hold?
VMAVX's largest holdings are Venerable US Large Cap Core Equity Fund (30.1%), Venerable US Large Cap Strategic Equity Fund (30.1%), Venerable High Yield Fund (19.9%), Venerable Strategic Bond Fund (19.8%). It holds 4 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
Who manages VMAVX?
VMAVX is offered by Venerable Variable Insurance through Venerable Variable Insurance Trust.